ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

The addition of mirabegron in pediatric lower urinary tract dysfunction: A large single-center experience

Study limitation reported by the research below: “Symptom improvement was defined by clinical documentation, not validated instruments (e.g., DVSS), which may introduce assessment variability.”

Papers